These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 1974067)

  • 21. A dose ratio comparison of the interaction between morphine and cyclazocine with naloxone in rhesus monkeys on the shock titration task.
    Yaksh TL; Rudy TA
    Eur J Pharmacol; 1977 Nov; 46(2):83-92. PubMed ID: 412680
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Limitations on the antagonistic actions of opioid antagonists.
    Young AM; Woods JH
    Fed Proc; 1982 May; 41(7):2333-8. PubMed ID: 7042396
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An investigation of the negative-reinforcing properties of naloxone and cyclazocine in squirrel monkeys.
    Stretch R; Pink C; Gervaize P
    Can J Physiol Pharmacol; 1980 Apr; 58(4):384-91. PubMed ID: 6770985
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of narcotic agonists and antagonists on schedule-induced water and morphine ingestion.
    Leander JD; McMillan DE; Harris LS
    J Pharmacol Exp Ther; 1975 Nov; 195(2):271-8. PubMed ID: 1237618
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reinforcing properties of stereoisomers of the putative sigma agonists N-allylnormetazocine and cyclazocine in rhesus monkeys.
    Slifer BL; Balster RL
    J Pharmacol Exp Ther; 1983 Jun; 225(3):522-8. PubMed ID: 6306209
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Discriminative effects of cyclazocine in the squirrel monkey.
    Schaefer GJ; Holtzman SG
    J Pharmacol Exp Ther; 1978 May; 205(2):291-301. PubMed ID: 417173
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Behavioral effects of selected opiates and phencyclidine in the nondependent and cyclazocine-dependent rhesus monkey.
    Bergman J; Hassoun J; Schuster CR
    J Pharmacol Exp Ther; 1985 Nov; 235(2):463-9. PubMed ID: 4057082
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Some behavioral effects of morphine, naloxone and nalorphine in the squirrel monkey and the pigeon.
    Goldberg SR; Morse WH; Goldberg DM
    J Pharmacol Exp Ther; 1976 Mar; 196(3):625-36. PubMed ID: 817014
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of serotonergic receptors in the effects of mu opioids in squirrel monkeys responding under a titration procedure.
    Powell KR; Dykstra LA
    Psychopharmacology (Berl); 1996 Jul; 126(1):42-9. PubMed ID: 8853215
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acute sensitization to opioid antagonists.
    White-Gbadebo D; Holtzman SG
    Pharmacol Biochem Behav; 1994 Mar; 47(3):559-66. PubMed ID: 8208774
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Discriminative stimulus effects of the opioid antagonist diprenorphine in the squirrel monkey.
    DeRossett SE; Holtzman SG
    J Pharmacol Exp Ther; 1986 May; 237(2):437-44. PubMed ID: 3009783
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vivo pharmacological characterization of SoRI 9409, a nonpeptidic opioid mu-agonist/delta-antagonist that produces limited antinociceptive tolerance and attenuates morphine physical dependence.
    Wells JL; Bartlett JL; Ananthan S; Bilsky EJ
    J Pharmacol Exp Ther; 2001 May; 297(2):597-605. PubMed ID: 11303048
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Behavioral effects of morphine and naloxone following chronic morphine administration.
    Dworkin SI; Branch MN
    Psychopharmacology (Berl); 1982; 77(4):322-6. PubMed ID: 6813891
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of the effects of opioid agonists and antagonists under a fixed-consecutive-number schedule in rats.
    Picker M; Heise JW; Dykstra LA
    Pharmacol Biochem Behav; 1987 May; 27(1):73-80. PubMed ID: 3615550
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Discriminative stimulus effects of the mixed-opioid agonist/antagonist dezocine: cross-substitution by mu and delta opioid agonists.
    Picker MJ
    J Pharmacol Exp Ther; 1997 Dec; 283(3):1009-17. PubMed ID: 9399970
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stereoisomers of N-allylnormetazocine: phencyclidine-like behavioral effects in squirrel monkeys and rats.
    Brady KT; Balster RL; May EL
    Science; 1982 Jan; 215(4529):178-80. PubMed ID: 6274022
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Agonist and antagonist activity of kappa opioids in the squirrel monkey: I. Antinociception and urine output.
    Craft RM; Dykstra LA
    J Pharmacol Exp Ther; 1992 Jan; 260(1):327-33. PubMed ID: 1309876
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Morphine antagonizes U50,488's effects in a squirrel monkey shock titration procedure.
    Craft RM; Dykstra LA
    Eur J Pharmacol; 1993 Apr; 234(2-3):199-207. PubMed ID: 8387010
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Behavioral effects of buprenorphine and diprenorphine under a multiple schedule of food presentation in squirrel monkeys.
    Dykstra LA
    J Pharmacol Exp Ther; 1983 Aug; 226(2):317-23. PubMed ID: 6875844
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Morphine, pentazocine and naloxone effects on responding under a multiple schedule of reinforcement in rhesus monkeys and pigeons.
    Downs DA; Woods JH
    J Pharmacol Exp Ther; 1976 Feb; 196(2):298-306. PubMed ID: 815542
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.